Autonomix Medical, Inc. Common Stock (AMIX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has a cash flow conversion efficiency ratio of -0.347x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.97 Million) by net assets ($8.56 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Autonomix Medical, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Autonomix Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AMIX liabilities breakdown for a breakdown of total debt and financial obligations.
Autonomix Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Madhucon Projects Limited
NSE:MADHUCON
|
-0.162x |
|
Pensionbee Group PLC
LSE:PBEE
|
-0.036x |
|
Ganga Forging Limited
NSE:GANGAFORGE
|
0.016x |
|
Enterprise Metals Ltd
AU:ENT
|
-0.023x |
|
Hopening SA
PA:MLHPE
|
N/A |
|
CQS New City High Yield Fund
LSE:NCYF
|
-0.028x |
|
Zelira Therapeutics Ltd
AU:ZLD
|
0.530x |
|
Austin Metals Ltd
AU:AYT
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Autonomix Medical, Inc. Common Stock (2022–2025)
The table below shows the annual cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see Autonomix Medical, Inc. Common Stock market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $8.10 Million | $-8.26 Million | -1.020x | -16.99% |
| 2024-03-31 | $7.63 Million | $-6.65 Million | -0.872x | +69.73% |
| 2023-03-31 | $644.00K | $-1.85 Million | -2.880x | -1356.83% |
| 2022-03-31 | $1.96 Million | $-387.31K | -0.198x | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresse… Read more